Free Trial

Globus Medical (GMED) Competitors

Globus Medical logo
$58.43 -0.85 (-1.43%)
As of 12:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

GMED vs. STE, PODD, BAX, HOLX, MASI, TFX, ITGR, ATEC, ATRC, and IART

Should you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Teleflex (TFX), Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "health care equipment" industry.

Globus Medical vs.

STERIS (NYSE:STE) and Globus Medical (NYSE:GMED) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, community ranking, valuation, risk, dividends, media sentiment and earnings.

STERIS has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.

STERIS has higher revenue and earnings than Globus Medical. STERIS is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STERIS$5.46B4.43$378.24M$6.2039.72
Globus Medical$2.51B3.25$122.87M$1.3444.23

94.7% of STERIS shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 1.1% of STERIS shares are held by insiders. Comparatively, 18.5% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

STERIS has a net margin of 8.66% compared to Globus Medical's net margin of 4.09%. STERIS's return on equity of 13.91% beat Globus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
STERIS8.66% 13.91% 8.64%
Globus Medical 4.09%10.83%8.63%

STERIS currently has a consensus target price of $264.00, indicating a potential upside of 7.19%. Globus Medical has a consensus target price of $94.00, indicating a potential upside of 58.60%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts plainly believe Globus Medical is more favorable than STERIS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STERIS
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Globus Medical
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

In the previous week, STERIS had 4 more articles in the media than Globus Medical. MarketBeat recorded 31 mentions for STERIS and 27 mentions for Globus Medical. STERIS's average media sentiment score of 0.98 beat Globus Medical's score of 0.89 indicating that STERIS is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STERIS
14 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Globus Medical
20 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Globus Medical received 232 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 67.33% of users gave Globus Medical an outperform vote while only 59.34% of users gave STERIS an outperform vote.

CompanyUnderperformOutperform
STERISOutperform Votes
343
59.34%
Underperform Votes
235
40.66%
Globus MedicalOutperform Votes
575
67.33%
Underperform Votes
279
32.67%

Summary

STERIS and Globus Medical tied by winning 9 of the 18 factors compared between the two stocks.

Get Globus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMED vs. The Competition

MetricGlobus MedicalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$8.15B$4.49B$5.37B$19.41B
Dividend YieldN/A43.63%5.22%3.83%
P/E Ratio79.0229.4326.8434.23
Price / Sales3.2567.72392.3434.85
Price / Cash23.3251.0838.2517.51
Price / Book2.026.236.794.69
Net Income$122.87M$68.16M$3.23B$1.02B
7 Day Performance2.61%-0.19%1.53%-1.74%
1 Month Performance-15.50%19.19%10.06%7.46%
1 Year Performance-11.74%21.47%16.72%3.96%

Globus Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMED
Globus Medical
4.8888 of 5 stars
$58.43
-1.4%
$94.00
+60.9%
-10.9%$8.04B$2.51B77.932,600Buyback Announcement
STE
STERIS
4.5613 of 5 stars
$232.89
+2.9%
$258.75
+11.1%
+6.8%$22.88B$5.40B49.4516,000News Coverage
Analyst Forecast
PODD
Insulet
4.4299 of 5 stars
$316.67
+1.9%
$303.81
-4.1%
+77.5%$22.28B$2.07B54.692,600Positive News
BAX
Baxter International
4.654 of 5 stars
$31.88
+3.2%
$37.25
+16.8%
-11.7%$16.36B$10.77B-24.9160,000Positive News
HOLX
Hologic
4.9561 of 5 stars
$58.81
+3.6%
$78.58
+33.6%
-26.5%$13.11B$4.03B18.556,940Positive News
MASI
Masimo
4.8457 of 5 stars
$163.56
+4.5%
$191.60
+17.1%
+20.0%$8.87B$2.13B112.806,200
TFX
Teleflex
4.9425 of 5 stars
$129.12
+3.2%
$164.63
+27.5%
-42.7%$5.71B$3.01B25.6715,500Analyst Revision
ITGR
Integer
2.6689 of 5 stars
$120.50
+1.7%
$145.56
+20.8%
-1.9%$4.20B$1.75B35.8610,000Analyst Upgrade
Analyst Revision
ATEC
Alphatec
4.0692 of 5 stars
$12.67
+3.8%
$17.89
+41.2%
+18.5%$1.85B$642.27M-9.90700Positive News
Insider Trade
ATRC
AtriCure
3.6136 of 5 stars
$31.81
+2.6%
$50.67
+59.3%
+48.2%$1.57B$480.08M-33.481,050Positive News
IART
Integra LifeSciences
4.4551 of 5 stars
$13.67
+11.6%
$18.63
+36.2%
-53.7%$1.06B$1.62B-151.873,720High Trading Volume

Related Companies and Tools


This page (NYSE:GMED) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners